LATEST PAPERS
Time With Glucose Level in Target Range Among Children and Adolescents With Type 1 Diabetes After a Software Update to a Closed-Loop Glucose Control System
Marigliano, M., Scaramuzza, A.E., Bonfanti, R., Rabbone, I., Schiaffini, R., Toni, S., Cherubini, V., Daga, F.A., Bassi, M., Berioli, M.G. and Bruzzi, P.
Aflibercept Monotherapy or Bevacizumab First for Diabetic Macular Edema
Jhaveri, C.D., Glassman, A.R., Ferris III, F.L., Liu, D., Maguire, M.G., Allen, J.B., Baker, C.W., Browning, D., Cunningham, M.A., Friedman, S.M. and Jampol, L.M.
Lower versus Higher Glycemic Criteria for Diagnosis of Gestational Diabetes
Crowther, C.A., Samuel, D., McCowan, L.M., Edlin, R., Tran, T. and McKinlay, C.J., 2022.
SARS-CoV-2 Infections and Presymptomatic Type 1 Diabetes Autoimmunity in Children and Adolescents From Colorado, USA, and Bavaria, Germany
Rewers, M., Bonifacio, E., Ewald, D., Rasmussen, C.G., Jia, X., Pyle, L., Ziegler, A.G., ASK Study Group and Fr1da Study Group, 2022.
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19
Bramante, C.T., Huling, J.D., Tignanelli, C.J., Buse, J.B., Liebovitz, D.M., Nicklas, J.M., Cohen, K., Puskarich, M.A., Belani, H.K., Proper, J.L. and Siegel, L.K.,
GO TO PAPERS
